Search

everythinglearnresearchcommunity

for

Search:↓

Terbinafine can cause hair loss.

Cyclosporin doesn't stop hair loss.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Many alopecia patients have undetected thyroid abnormalities that can be found through physical exams.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

A gluten-free diet stopped a child's hair-eating behavior and suggested she had celiac disease.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Rosacea is a skin condition with unclear causes, classified into four subtypes.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.